BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22996169)

  • 1. A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer.
    Luo S; Yi M; Huang X; Hunt KK
    Stat Med; 2013 Jun; 32(13):2320-34. PubMed ID: 22996169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.
    Luo S; Su X; DeSantis SM; Huang X; Yi M; Hunt KK
    Stat Med; 2014 Jul; 33(15):2554-66. PubMed ID: 24473943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous inference of a misclassified outcome and competing risks failure time data.
    Luo S; Su X; Yi M; Hunt KK
    J Appl Stat; 2015; 42(5):1080-1090. PubMed ID: 25821331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.
    Smith TE; Lee D; Turner BC; Carter D; Haffty BG
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1281-9. PubMed ID: 11121624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
    Yi M; Buchholz TA; Meric-Bernstam F; Bedrosian I; Hwang RF; Ross MI; Kuerer HM; Luo S; Gonzalez-Angulo AM; Buzdar AU; Symmans WF; Feig BW; Lucci A; Huang EH; Hunt KK
    Ann Surg; 2011 Mar; 253(3):572-9. PubMed ID: 21209588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Tanaka-Akashi S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Breast Cancer; 2005; 12(2):104-11. PubMed ID: 15858440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network meta-analysis of margin threshold for women with ductal carcinoma in situ.
    Wang SY; Chu H; Shamliyan T; Jalal H; Kuntz KM; Kane RL; Virnig BA
    J Natl Cancer Inst; 2012 Apr; 104(7):507-16. PubMed ID: 22440677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.
    Gosset M; Hamy AS; Mallon P; Delomenie M; Mouttet D; Pierga JY; Lae M; Fourquet A; Rouzier R; Reyal F; Feron JG
    PLoS One; 2016; 11(8):e0159888. PubMed ID: 27494111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination.
    Sakai T; Nishimura S; Ogiya A; Tanabe M; Kimura K; Morizono H; Iijima K; Miyagi Y; Makita M; Ito Y; Oguchi M; Horii R; Akiyama F; Iwase T
    Pathol Int; 2015 Mar; 65(3):113-8. PubMed ID: 25600703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inference on cancer screening exam accuracy using population-level administrative data.
    Jiang H; Brown PE; Walter SD
    Stat Med; 2016 Jan; 35(1):130-46. PubMed ID: 26278587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binary regression with misclassified response and covariate subject to measurement error: a bayesian approach.
    McGlothlin A; Stamey JD; Seaman JW
    Biom J; 2008 Feb; 50(1):123-34. PubMed ID: 18283683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment.
    Yoshida T; Takei H; Kurosumi M; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Oba H; Kawanowa K; Inoue K; Tabei T
    Breast J; 2010; 16(2):127-33. PubMed ID: 20030655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation.
    Alpert TE; Kuerer HM; Arthur DW; Lannin DR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):845-51. PubMed ID: 16199315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence.
    Dalberg K; Liedberg A; Johansson U; Rutqvist LE
    Eur J Surg Oncol; 2003 Mar; 29(2):143-54. PubMed ID: 12633557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
    Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
    J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy.
    Panet-Raymond V; Truong PT; McDonald RE; Alexander C; Ross L; Ryhorchuk A; Watson PH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):409-17. PubMed ID: 21288654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Monte Carlo error in the Bayesian estimation of risk ratios using log-binomial regression models.
    Salmerón D; Cano JA; Chirlaque MD
    Stat Med; 2015 Aug; 34(19):2755-67. PubMed ID: 25944082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian semi-parametric ROC analysis.
    Erkanli A; Sung M; Costello EJ; Angold A
    Stat Med; 2006 Nov; 25(22):3905-28. PubMed ID: 16416403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.